The stock's fall snapped a three-day winning streak.

KeyBanc analyst Scott Schoenhaus lowered the firm’s price target on Health Catalyst (HCAT) to $5 from $7 and keeps an Overweight rating on the ...

BOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud to announce the release of the Epilepsy & Seizure Safe Classrooms Toolkit, a comprehensive educational ...

OpenAI declined to comment, while Windsurf, formerly known as Codeium, did not immediately respond to a Reuters request for ...

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...